ArticleClinical kidney journal2026
Gender disparities in Swedish specialized nephrology care.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although women have more prevalent chronic kidney disease (CKD) they less often have recommended therapy or a documented CKD diagnosis in primary care. This study investigates whether gender disparities remain in specialized nephrology care as a possible expression of gender bias. Methods: Patients with incident estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m Results: Of 25 478 included patients 37% were female. Women were less likely to have a CKD diagnosis [odds ratio (OR) 0.81, 95% confidence interval 0.73-0.90], a renin-angiotensin-aldosterone inhibitor (OR 0.94, 0.89-0.99), lipid-lowering agent (OR 0.93, 0.88-0.99) or BP <140/90 mmHg (OR 0.91, 0.86-0.97). Women had borderline-significantly lower odds of having a kidney biopsy (OR 0.93, 0.86-1.00). Women were less likely to initiate KRT, [hazard ratio (HR) 0.75, 0.70-0.80] or to initiate dialysis with a planned access (HR 0.82, 0.78-0.85). No significant gender differences were seen regarding preemptive transplantation and conservative kidney management decision. Women less often died before KRT initiation (HR 0.81, 0.77-0.85). Conclusions: Swedish women with advanced CKD in specialized nephrology remain underdiagnosed, undertreated and less likely to reach BP targets. Although these gender differences did not translate to increased KRT and mortality rates, they highlight the need for nephrologists to maintain awareness and strive for health equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.